Standout Papers

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanc... 2010 2026 2015 2020 580
  1. Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 (2010)
    Mark P. Chao, Siddhartha Jaiswal et al. Science Translational Medicine

Immediate Impact

10 by Nobel laureates 22 from Science/Nature 73 standout
Sub-graph 1 of 19

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Physiology and diseases of tissue-resident macrophages
2023 StandoutNature
6 intermediate papers

Works of Tal Raveh being referenced

Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
2021
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
2010 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Tal Raveh 1353 717 36 482 21 2.4k
C H Heldin 1637 565 551 26 3.0k
Maria-Magdalena Georgescu 1736 489 2 334 28 2.5k
Steven Swendeman 1642 506 5 597 35 2.6k
Christine R. Norton 1669 615 23 445 24 3.0k
Katrin Busch 1326 1832 346 18 3.4k
N A Jenkins 2095 694 7 365 37 3.4k
David J. Izon 2094 1443 3 594 49 3.7k
Catherine Lavau 3331 546 372 41 4.0k
Maria De La Luz Sierra 1013 349 2 383 32 1.9k
David Shahbazian 2054 418 4 553 17 2.8k

All Works

Loading papers...

Rankless by CCL
2026